Global Recombinant Vaccine Market Report By Product (Subunit Recombinant Vaccine, Attenuated Recombinant Vaccine And Vector Recombinant Vaccine), End-User (Recombinant Human Vaccine And Animal Recombinant Vaccine) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210560
February 2020
Report Formats:

As per this study the Global Recombinant Vaccine Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%. By volume, the market was estimated XX.X KT in 2019 and is expected to reach XX.X KT by 2026 with a CAGR of X.X%.

Recombinant vaccine refers to the biological suspension developed using recombinant DNA technology. The recombinant vaccine is produced by introducing genetic material of dead or attenuated antigen into the host body through a vector that results in stimulation of immune response. It is useful to offer resistance to malaria, typhoid, allergies, cancer, and various infectious diseases such as Ebola, Flu, HPV, measles, smallpox, etc.
 
Market Dynamics
 
Growing health threat on account of widespread of infectious diseases and increasing prevalence of cancer is driving the market growth. Rise in immunization programs by the government to promote resistant to diseases is further fueling the market demand. Ongoing advancement in the field of immunology, molecular biology, biochemistry, genomics, and proteomics is again boosting the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of recombinant vaccine.
 
Market Segmentation
 
The broad recombinant vaccine market has been sub-grouped into product and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Subunit Recombinant Vaccine
  • Attenuated Recombinant Vaccine
  • Vector Recombinant Vaccine
 
By End-User
  • Recombinant Human Vaccine
  • Animal Recombinant Vaccine
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for recombinant vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Recombinant Vaccine Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the recombinant vaccine market include Bayer AG, Bharat Biotech, GlaxoSmithKline Plc., Green Cross Corporation, Merck & Co., Inc., Novartis AG, Pfizer Inc., Protein Science Corporation and Sanofi S A. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Recombinant Vaccine  Market
       2.2. Global Recombinant Vaccine  Market Snapshot
 
3 . RECOMBINANT VACCINE  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Recombinant Vaccine  Market
       3.3. Market Restraints of Recombinant Vaccine  Market
       3.4. Opportunities of Recombinant Vaccine  Market
       3.5. Trends of Recombinant Vaccine  Market
       3.6. Porter’s Five Force Analysis of Recombinant Vaccine  Market
       3.7. Recombinant Vaccine  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by End-User
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Recombinant Vaccine  Value Chain Analysis
       4.2. Recombinant Vaccine  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Recombinant Vaccine  Raw Material Manufactures List
           4.2.3. Price Trend of Recombinant Vaccine  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL RECOMBINANT VACCINE  MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Recombinant Vaccine  Market Analysis by Product
       5.3 Market Analysis of Subunit Recombinant Vaccine by Regions
       5.4 Market Analysis of Attenuated Recombinant Vaccine by Regions
       5.5 Market Analysis of Vector Recombinant Vaccine by Regions
 
6 . GLOBAL RECOMBINANT VACCINE  MARKET ANALYSIS BY END-USER
       6.1 Overview by End-User
       6.2 Global Recombinant Vaccine  Market Analysis by End-User
       6.3 Market Analysis of Recombinant Human Vaccine by Regions
       6.4 Market Analysis of Animal Recombinant Vaccine by Regions
 
7 . GLOBAL RECOMBINANT VACCINE  MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Recombinant Vaccine  Market Estimate by Market Segment
           7.3.3. North America Recombinant Vaccine  Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Recombinant Vaccine  Market Estimate by Market Segment
           7.4.3. Europe Recombinant Vaccine  Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Recombinant Vaccine  Market Estimate by Market Segment
           7.5.3. Asia Pacific Recombinant Vaccine  Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Recombinant Vaccine  Market Estimate by Market Segment
           7.6.3. Latin America Recombinant Vaccine  Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Recombinant Vaccine  Market Estimate by Market Segment
           7.7.3. Middle East & Africa Recombinant Vaccine  Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT VACCINE  COMPANIES
       8.1. Recombinant Vaccine  Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF RECOMBINANT VACCINE  INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Bayer AG
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bharat Biotech
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. GlaxoSmithKline Plc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Green Cross Corporation
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Merck & Co., Inc
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Novartis AG
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Pfizer Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Protein Science Corporation
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Sanofi S A.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Global Recombinant Vaccine  Market Analysis in Subunit Recombinant Vaccine by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis in Subunit Recombinant Vaccine by Geography (USD MN)
  • Global Recombinant Vaccine  Market Analysis in Attenuated Recombinant Vaccine by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis in Attenuated Recombinant Vaccine by Geography (USD MN)
  • Global Recombinant Vaccine  Market Analysis in Vector Recombinant Vaccine by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis in Vector Recombinant Vaccine by Geography (USD MN)
  • Global Recombinant Vaccine  Market Analysis by End-User (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis by End-User (USD MN)
  • Global Recombinant Vaccine  Market Analysis in Recombinant Human Vaccine by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis in Recombinant Human Vaccine by Geography (USD MN)
  • Global Recombinant Vaccine  Market Analysis in Animal Recombinant Vaccine by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market Analysis in Animal Recombinant Vaccine by Geography (USD MN)
  • Global Recombinant Vaccine  Market by Geography (Kilo Tons)
  • Global Recombinant Vaccine  Market by Geography (USD MN)
  • North America Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • North America Recombinant Vaccine  Market Analysis by Product (USD MN)
  • North America Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • North America Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • North America Recombinant Vaccine  Market Estimate by Country (Kilo Tons)
  • North America Recombinant Vaccine  Market Estimate by Country (USD MN)
  • United State Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • United State Recombinant Vaccine  Market Analysis by Product (USD MN)
  • United State Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • United State Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Rest of North America Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Rest of North America Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Rest of North America Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Rest of North America Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Europe Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Europe Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Europe Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Europe Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Europe Recombinant Vaccine  Market Estimate by Country (Kilo Tons)
  • Europe Recombinant Vaccine  Market Estimate by Country (USD MN)
  • United Kingdom Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • United Kingdom Recombinant Vaccine  Market Analysis by Product (USD MN)
  • United Kingdom Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • United Kingdom Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • France Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • France Recombinant Vaccine  Market Analysis by Product (USD MN)
  • France Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • France Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Germany Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Germany Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Germany Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Germany Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Rest of Europe Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Rest of Europe Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Rest of Europe Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Rest of Europe Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Asia Pacific Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Asia Pacific Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Asia Pacific Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Asia Pacific Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Asia Pacific Recombinant Vaccine  Market Estimate by Country (Kilo Tons)
  • Asia Pacific Recombinant Vaccine  Market Estimate by Country (USD MN)
  • China Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • China Recombinant Vaccine  Market Analysis by Product (USD MN)
  • China Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • China Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Japan Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Japan Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Japan Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Japan Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • India Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • India Recombinant Vaccine  Market Analysis by Product (USD MN)
  • India Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • India Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Rest of Asia Pacific Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Rest of Asia Pacific Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Rest of Asia Pacific Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Latin America Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Latin America Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Latin America Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Latin America Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Latin America Recombinant Vaccine  Market Estimate by Country (Kilo Tons)
  • Latin America Recombinant Vaccine  Market Estimate by Country (USD MN)
  • Brazil Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Brazil Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Brazil Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Brazil Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Rest of Latin America Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Rest of Latin America Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Rest of Latin America Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Rest of Latin America Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Middle East & Africa Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Middle East & Africa Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Middle East & Africa Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Middle East & Africa Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Middle East & Africa Recombinant Vaccine  Market Estimate by Country (Kilo Tons)
  • Middle East & Africa Recombinant Vaccine  Market Estimate by Country (USD MN)
  • Middle East Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Middle East Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Middle East Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Middle East Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Africa Recombinant Vaccine  Market Analysis by Product (Kilo Tons)
  • Africa Recombinant Vaccine  Market Analysis by Product (USD MN)
  • Africa Recombinant Vaccine  Market Estimate by End-User (Kilo Tons)
  • Africa Recombinant Vaccine  Market Estimate by End-User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
  • Research Scope of Recombinant Vaccine  Report
  • Market Research Process
  • Market Research Methodology
  • Global Recombinant Vaccine  Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Recombinant Vaccine  Market Analysis by Product
  • Global Recombinant Vaccine  Market Analysis in Subunit Recombinant Vaccine by Region
  • Global Recombinant Vaccine  Market Analysis in Attenuated Recombinant Vaccine by Region
  • Global Recombinant Vaccine  Market Analysis in Vector Recombinant Vaccine by Region
  • Global Recombinant Vaccine  Market Analysis by End-User
  • Global Recombinant Vaccine  Market Analysis in Recombinant Human Vaccine by Region
  • Global Recombinant Vaccine  Market Analysis in Animal Recombinant Vaccine by Region
  • Global Recombinant Vaccine  Market by Volume And Revenue
  • North America Recombinant Vaccine  Market by Volume And Revenue
  • Europe Recombinant Vaccine  Market by Volume And Revenue
  • Asia Pacific Recombinant Vaccine  Market by Volume And Revenue
  • Latin America Recombinant Vaccine  Market by Volume And Revenue
  • Middle East & Africa Recombinant Vaccine  Market by Volume And Revenue
  • Recent Development in Recombinant Vaccine  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials